REMINDER: Our user survey closes on Friday, please submit your responses here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDVRG.L Regulatory News (DVRG)

  • There is currently no data for DVRG

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

8 Feb 2021 07:00

RNS Number : 2312O
Deepverge PLC
08 February 2021
 

8 February 2021

 

DeepVerge PLC

 

("DeepVerge" or "Company")

 

Director/PDMR Shareholding

The Company was notified on 5 February that Mrs Dagmara Brandon, the wife of Mr Gerard Brandon, the Company's Chief Executive, had on 4 February sold 194,942 ordinary shares of 0.1p each ("Ordinary Shares") at an average price of 32.05 pence per share. Mr Brandon's shareholding remains at 8,219,901 shares, representing 4.83 per cent. of the Company's issued share capital.

As a result of this share disposal, the Board has become aware that, inadvertently, Mrs Brandon's holding has not been included in Mr Brandon's shareholding disclosed in previous "Director/PDMR Shareholding" notifications since she acquired these shares on 20 November 2018 at an equivalent price of 6.5p per share (taking account of the recent 10:1 share consolidation).

Gerry Brandon, CEO of DeepVerge, commented:

 

"The 194,942 shares were owned by my wife and she is using £50,000 of the total proceeds of her disposal to acquire 50,000,000 ordinary shares in Microsaic Systems plc. The timing of the disposal directly relates to the settlement date of the Placing announced on 5 February in a separate notification from Microsaic Systems plc."

FORM FOR NOTIFYING DEALINGS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM.

 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

 

Dagmara Brandon, wife of Gerard Brandon

2

Reason for the notification

a)

Position/status

PCA with DeepVerge's Chief Executive Officer (PDMR)

b)

Initial notification/ Amendment

Initial

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

DeepVerge PLC

b)

LEI

213800M477RQVVHVUD72

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument Identification code

Ordinary shares of 0.1 pence each

Identification code GB00BMGWZY29

 

b)

Nature of the transaction

Disposal

c)

Price(s) and volume(s)

 

Price(s)

Volume(s)

32.05 pence

100,000

32.00 pence

44,942

32.10 pence

50,000

d)

Aggregated information - Aggregated volume and Price

Price(s)

Volume(s)

32.05 pence

194,942

 

Total - £62,481.44

e)

Date of the transaction

4 February 2021

f)

Place of the transaction

X.LON

 

Market Abuse Regulation (MAR) Disclosure

 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION AS STIPULATED UNDER THE UK VERSION OF THE MARKET ABUSE REGULATION NO 596/2014 WHICH IS PART OF ENGLISH LAW BY VIRTUE OF THE EUROPEAN (WITHDRAWAL) ACT 2018, AS AMENDED. ON PUBLICATION OF THIS ANNOUNCEMENT VIA A REGULATORY INFORMATION SERVICE, THIS INFORMATION IS CONSIDERED TO BE IN THE PUBLIC DOMAIN.

 

Enquiries:

 

DeepVerge plc

Ross Andrews, Chairman

+44 (0) 7340 055 648

SPARK Advisory Partners Limited

(Nominated Adviser)

Neil Baldwin

+44 (0) 113 370 8974

Turner Pope Investments (TPI) Limited

(Broker)

Andy Thacker/Zoe Alexander

+44 (0) 20 3657 0050

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHEAAAKEDXFEFA
Date   Source Headline
30th Sep 20224:35 pmRNSPrice Monitoring Extension
30th Sep 202211:06 amRNSSecond Price Monitoring Extn
30th Sep 202211:00 amRNSPrice Monitoring Extension
22nd Sep 20227:00 amRNSInterim Results
13th Sep 20227:00 amRNSBlue Carbon Resilience project
5th Aug 20227:00 amRNSTrading Update
1st Aug 20227:00 amRNSModern Water secures £2.1m projects
20th Jul 20221:42 pmRNSResult of AGM
20th Jul 20227:00 amRNSDeepVerge to explore options for Labskin Division
19th Jul 20224:41 pmRNSSecond Price Monitoring Extn
19th Jul 20224:36 pmRNSPrice Monitoring Extension
18th Jul 20227:01 amRNSModern Water monitoring systems deal worth £1.4m
4th Jul 20227:00 amRNSSkin Trust Club - update
30th Jun 20227:00 amRNSModern Water Q2 orders exceed £3m, RPT
27th Jun 202211:50 amRNSNotice of AGM
23rd Jun 20227:12 amRNSFinal Results
13th Jun 20227:00 amRNSNotice of Final Results and Annual Report
1st Jun 20221:36 pmRNSSkin Trust Club wins Best New Disrupter Brand
30th May 20227:00 amRNSTesting Services Framework Ag with Abingdon Health
26th Apr 20227:00 amRNSDeepVerge presents at Global Group Investor Summit
19th Apr 20227:00 amRNSUpdate; Manuf'g Service Agreement with Microsaic
19th Apr 20227:00 amRNSHolding(s) in Company
29th Mar 20227:00 amRNSMoU with Abingdon Health for lateral flow tests
28th Mar 20227:00 amRNS1st UK Deployments of Microtox®PD in Wastewater
18th Mar 202211:05 amRNSSecond Price Monitoring Extn
18th Mar 202211:00 amRNSPrice Monitoring Extension
17th Mar 202210:59 amRNSDirector Dealing
17th Mar 20227:00 amRNSAcquisition; Loan Facility for global expansion
11th Mar 20229:05 amRNSSecond Price Monitoring Extn
11th Mar 20229:00 amRNSPrice Monitoring Extension
11th Mar 20227:00 amRNSDeepVerge Q1 production orders up 39% to £5m
21st Feb 20227:00 amRNS82% of Skin Trust Club members purchase via App
19th Jan 20227:00 amRNSMicrotoxPD detects 3 COVID variants of concern
17th Jan 202211:05 amRNSSecond Price Monitoring Extn
17th Jan 202211:00 amRNSPrice Monitoring Extension
11th Jan 20227:00 amRNSTrading Update
6th Jan 20227:00 amRNSMicrotox CTM installed ahead of Winter Olympics
13th Dec 20217:00 amRNSAmends to Agreement with Microsaic Systems; RPT
10th Dec 20219:00 amRNSPrice Monitoring Extension
10th Dec 20217:00 amRNSCompact Microtox® PD launch scheduled for Q1 2022
9th Dec 20214:41 pmRNSSecond Price Monitoring Extn
9th Dec 20214:36 pmRNSPrice Monitoring Extension
26th Nov 20217:00 amRNSRelated Party Transaction
11th Nov 20217:00 amRNSU.S. launch of Skin Trust Club at Beauty Connect
4th Nov 20218:00 amRNSPDMR Dealing
4th Nov 20217:00 amRNSGrant supports DeepVerge Centre of Excellence
3rd Nov 20217:00 amRNSConfirmation of Post-Offer Intention Statements
28th Oct 20217:00 amRNSMicrotox® PD installations as part of nat'l trial
21st Oct 20219:05 amRNSSecond Price Monitoring Extn
21st Oct 20219:00 amRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.